Click for best price
Psoriatic Arthritis Therapeutics Market Size, Share 2023
| Market size in 2022 |
US$ 6585.3 million
|
Forecast Market size by 2029 |
US$ 11710 million
|
| Growth Rate |
CAGR of 8.6% |
Number of Pages |
63 Pages |
The global Psoriatic Arthritis Therapeutics market was valued at US$ 6585.3 million in 2022 and is projected to reach US$ 11710 million by 2029, at a CAGR of 8.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Psoriatic Arthritis Therapeutics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Psoriatic Arthritis Therapeutics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Psoriatic Arthritis Therapeutics market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Therapeutics. This report contains market size and forecasts of Psoriatic Arthritis Therapeutics in global, including the following market information:
- Global Psoriatic Arthritis Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global psoriatic arthritis therapeutics market is expected to grow rapidly over the forecast period owing to the increasing prevalence rate of psoriatic arthritis.
We surveyed the Psoriatic Arthritis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psoriatic Arthritis Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Psoriatic Arthritis Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Nonsteroidal Anti-Inflammatory Drug
- Disease-Modifying Antirheumatic Drug
- Biologic Drug
- Enzyme Inhibitor
Global Psoriatic Arthritis Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Psoriatic Arthritis Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinics
- Research Labs
Global Psoriatic Arthritis Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Psoriatic Arthritis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Psoriatic Arthritis Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Psoriatic Arthritis Therapeutics revenues share in global market, 2022 (%)
key players include:
- Pfizer
- Bayer
- Novartis
- Abbott Laboratories
- Sanofi
- Bristol-Myers Squibb
- Janssen Biotech
- Amgen
- UCB
- AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psoriatic Arthritis Therapeutics, market overview.
Chapter 2: Global Psoriatic Arthritis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Psoriatic Arthritis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psoriatic Arthritis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Psoriatic Arthritis Therapeutics Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 6585.3 million
|
| Forecast Market size by 2029 |
US$ 11710 million
|
| Growth Rate |
CAGR of 8.6% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Psoriatic Arthritis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psoriatic Arthritis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psoriatic Arthritis Therapeutics Overall Market Size
2.1 Global Psoriatic Arthritis Therapeutics Market Size: 2022 VS 2030
2.2 Global Psoriatic Arthritis Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Psoriatic Arthritis Therapeutics Players in Global Market
3.2 Top Global Psoriatic Arthritis Therapeutics Companies Ranked by Revenue
3.3 Global Psoriatic Arthritis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Psoriatic Arthritis Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Psoriatic Arthritis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psoriatic Arthritis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Psoriatic Arthritis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Psoriatic Arthritis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Psoriatic Arthritis Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Nonsteroidal Anti-Inflammatory Drug
4.1.3 Disease-Modifying Antirheumatic Drug
4.1.4 Biologic Drug
4.1.5 Enzyme Inhibitor
4.2 By Type - Global Psoriatic Arthritis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Psoriatic Arthritis Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Psoriatic Arthritis Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Psoriatic Arthritis Therapeutics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Labs
5.2 By Application - Global Psoriatic Arthritis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Psoriatic Arthritis Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Psoriatic Arthritis Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Psoriatic Arthritis Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Psoriatic Arthritis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Psoriatic Arthritis Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Psoriatic Arthritis Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Psoriatic Arthritis Therapeutics Revenue, 2018-2030
6.3.2 US Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.3.3 Canada Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.3.4 Mexico Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Psoriatic Arthritis Therapeutics Revenue, 2018-2030
6.4.2 Germany Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.4.3 France Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.4.4 U.K. Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.4.5 Italy Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.4.6 Russia Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.4.8 Benelux Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Psoriatic Arthritis Therapeutics Revenue, 2018-2030
6.5.2 China Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.5.3 Japan Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.5.4 South Korea Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.5.6 India Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Psoriatic Arthritis Therapeutics Revenue, 2018-2030
6.6.2 Brazil Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.6.3 Argentina Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Psoriatic Arthritis Therapeutics Revenue, 2018-2030
6.7.2 Turkey Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.7.3 Israel Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Psoriatic Arthritis Therapeutics Market Size, 2018-2030
6.7.5 UAE Psoriatic Arthritis Therapeutics Market Size, 2018-2030
7 Psoriatic Arthritis Therapeutics Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Psoriatic Arthritis Therapeutics Major Product Offerings
7.1.4 Pfizer Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Psoriatic Arthritis Therapeutics Major Product Offerings
7.2.4 Bayer Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Psoriatic Arthritis Therapeutics Major Product Offerings
7.3.4 Novartis Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Major Product Offerings
7.4.4 Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Psoriatic Arthritis Therapeutics Major Product Offerings
7.5.4 Sanofi Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Major Product Offerings
7.6.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Janssen Biotech
7.7.1 Janssen Biotech Company Summary
7.7.2 Janssen Biotech Business Overview
7.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Major Product Offerings
7.7.4 Janssen Biotech Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Janssen Biotech Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Psoriatic Arthritis Therapeutics Major Product Offerings
7.8.4 Amgen Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 UCB
7.9.1 UCB Company Summary
7.9.2 UCB Business Overview
7.9.3 UCB Psoriatic Arthritis Therapeutics Major Product Offerings
7.9.4 UCB Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.9.5 UCB Key News & Latest Developments
7.10 AbbVie
7.10.1 AbbVie Company Summary
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Psoriatic Arthritis Therapeutics Major Product Offerings
7.10.4 AbbVie Psoriatic Arthritis Therapeutics Revenue in Global Market (2018-2023)
7.10.5 AbbVie Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Psoriatic Arthritis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Psoriatic Arthritis Therapeutics Market Drivers in Global Market
Table 3. Psoriatic Arthritis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Psoriatic Arthritis Therapeutics in Global Market
Table 5. Top Psoriatic Arthritis Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Psoriatic Arthritis Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Psoriatic Arthritis Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Psoriatic Arthritis Therapeutics Product Type
Table 9. List of Global Tier 1 Psoriatic Arthritis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psoriatic Arthritis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Psoriatic Arthritis Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Psoriatic Arthritis Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Psoriatic Arthritis Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Psoriatic Arthritis Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Psoriatic Arthritis Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Psoriatic Arthritis Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. Pfizer Company Summary
Table 31. Pfizer Psoriatic Arthritis Therapeutics Product Offerings
Table 32. Pfizer Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Psoriatic Arthritis Therapeutics Product Offerings
Table 36. Bayer Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Psoriatic Arthritis Therapeutics Product Offerings
Table 40. Novartis Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Abbott Laboratories Company Summary
Table 43. Abbott Laboratories Psoriatic Arthritis Therapeutics Product Offerings
Table 44. Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Laboratories Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Psoriatic Arthritis Therapeutics Product Offerings
Table 48. Sanofi Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product Offerings
Table 52. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Janssen Biotech Company Summary
Table 55. Janssen Biotech Psoriatic Arthritis Therapeutics Product Offerings
Table 56. Janssen Biotech Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Janssen Biotech Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Psoriatic Arthritis Therapeutics Product Offerings
Table 60. Amgen Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. UCB Company Summary
Table 63. UCB Psoriatic Arthritis Therapeutics Product Offerings
Table 64. UCB Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. UCB Key News & Latest Developments
Table 66. AbbVie Company Summary
Table 67. AbbVie Psoriatic Arthritis Therapeutics Product Offerings
Table 68. AbbVie Psoriatic Arthritis Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. AbbVie Key News & Latest Developments
List of Figures
Figure 1. Psoriatic Arthritis Therapeutics Segment by Type in 2022
Figure 2. Psoriatic Arthritis Therapeutics Segment by Application in 2022
Figure 3. Global Psoriatic Arthritis Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Psoriatic Arthritis Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Psoriatic Arthritis Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Psoriatic Arthritis Therapeutics Revenue in 2022
Figure 8. By Type - Global Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Psoriatic Arthritis Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Psoriatic Arthritis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Pfizer Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Janssen Biotech Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Amgen Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. UCB Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AbbVie Psoriatic Arthritis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
